Alfonso Cortés Salgado
@AlfonsoCorts9
Followers
770
Following
3K
Media
12
Statuses
857
Medical Oncologist | Breast & Gynaecological tumors | Ramón y Cajal University Hospital
Madrid, Comunidad de Madrid
Joined December 2018
📣 📣 We are thrilled to share our latest article on HER2 expression in endometrial cancer!. 🔬193 cases. HER2-low:.⬛️entire cohort 25.8%.🟥p53abn 45.1%.🟩dMMR 12.5%.🟧 NSMP 19.7%.🟦POLE 66.7% (4/6 cases). Endometrial & gastric HER2 criteria👍🏼.Breast criteria 👎🏼
5
5
26
RT @OncoAlert: Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refract….
0
9
0
RT @KenRoth: "We faced hunger before, but never like this": skeletal children fill hospital wards as starvation grips Gaza due to Israel's….
theguardian.com
For months Israel kept food shipments to Gaza far below starvation rations. Now the death toll is rising rapidly
0
739
0
RT @LungCancerEu: 🚨 #Lungcancer survival has more than doubled. New real-world data from France shows 3-year survival for lung adenocarcin….
0
131
0
RT @oncodaily: 20 Posts Not to Miss from ESMO Gynaecological Cancers Congress 2025.@myESMO . @AinhoaMada | @AlfonsoCorts9 | @AnaOaknin | @….
oncodaily.com
The 16th ESMO Gynaecological Cancers Congress 2025 was held in Florence, Italy, from June 19 to 21, uniting oncologists, researchers, and healt
0
5
0
Truly proud to share our work at #ESMOgynae25 this weekend: “Bevacizumab (Bev) in Platinum-Resistant Ovarian Cancer: Does prior exposure to Bev affect outcomes?” Grateful for the passion and dedication of our fellow Dr Calvo. More data coming soon… #GynOnc @OncoMedRyC
0
1
20
RT @brennanjp: Spanish national team watching Alcaraz battle it out one hour before playing a Final of their own. Incredible photo. 🇪🇸 htt….
0
2K
0
RT @PTarantinoMD: Interesting phase 2 trial of 1L taxol/atezo/beva for (mostly) PDL1- mTNBC (n=100) out in @NatureMedicine. ORR 63%, mPFS 1….
0
43
0
RT @oncology_bg: The most practice changing trial from #ASCO25 is now live on @NEJM .If this was a drug, this would be approved today. Glob….
0
303
0
RT @OncoAlert: NEWS FROM INDUSTRY: SOURCE MERCK. KEYNOTE-B96 Update #OvarianCancer. The Phase 3 KEYNOTE-B96 (ENGOT-ov65) trial demonstrated….
0
14
0
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism | New England Journal of Medicine
nejm.org
In patients with active cancer and venous thromboembolism, whether extended treatment with a reduced dose of an oral anticoagulant is effective in preventing recurrent thromboembolic events and dec...
0
0
0
RT @tuttsakhil: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site:….
esmoopen.com
Knowledge about the association between the BRCA1/2 mutation type and location and response to poly (ADP-ribose) polymerase inhibitors (PARPis) as single agent in ovarian cancer is limited. This...
0
4
0
Efficacy of Hand Cooling and Compression in Preventing Taxane-Induced Neuropathy: The POLAR Randomized Clinical Trial | Clinical Pharmacy and Pharmacology | JAMA Oncology | JAMA Network
jamanetwork.com
This randomized clinical trial evaluates the efficacy of hand cooling and compression in reducing the risk of chemotherapy-induced peripheral neuropathy in patients with breast cancer.
0
2
4
RT @SantiCabezas1: ctDNA detection in cerebrospinal fluid and plasma and mutational concordance with the primary tumor in a multicenter pro….
0
11
0
And we will continue studying endometrial cancer thanks to the “Andrés Poveda” Grant from @GEICOgroup.
0
1
8